In one paragraphArticle in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Robin M PerelliDivision of Cardiology, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0002-5120-0470 Yiu Yan SiuDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.
Anna TornatoreDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.
Josue NatarenDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.
Craig HenriquezDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.
Andrew P LandstromDivision of Cardiology, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0002-1878-9631 Funding
Project 3 - Role of Proline Metabolism in Regulation of Mammalian Cardiomyocyte ProliferationP01HL160476 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Hesham Sadek · 2022 to 2026
$13.1MIntegrated Cellular and Tissue Engineering for Ischemic Heart DiseaseU01HL134764 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BURSAC, NENAD, KAMP, TIMOTHY J. · 2016 to 2022
$7.7MEngineering Human Heart Tissues with Polyploid CardiomyocytesR01HL164013 · NHLBI · DUKE UNIVERSITY · PI BURSAC, NENAD · 2022 to 2025
$2.2MIn Vitro and In Situ Engineering of Fibroblasts for Cardiac RepairR01HL132389 · NHLBI · DUKE UNIVERSITY · PI BURSAC, NENAD · 2016 to 2019
$2.0MEngineered BacNav and BacCav for Improved Excitability and ContractionR01EB032726 · NIBIB · DUKE UNIVERSITY · PI BURSAC, NENAD · 2022 to 2025
$1.9MEngineering of Human Excitable Tissues from Unexcitable CellsR01HL126524 · NHLBI · DUKE UNIVERSITY · PI BURSAC, NENAD · 2016 to 2019
$1.9MInvestigating Mitogenic Mechanism and Therapeutic Efficacy of Adenosine Deaminase Knockout in Human and Murine CardiomyocytesF31HL162460 · NHLBI · DUKE UNIVERSITY · PI DELUCA, SOPHIA BUNNELL · 2022 to 2023
$84kNHLBI NIH HHS F31 HL162460NHLBI NIH HHS P01 HL160476NHLBI NIH HHS R01 HL126524NHLBI NIH HHS R01 HL132389NHLBI NIH HHS R01 HL164013NHLBI NIH HHS U01 HL134764NIBIB NIH HHS R01 EB032726
6 · The paper itselfAbstract
Despite continued progress, therapies to augment contractile function and prevent arrhythmias in patients with heart failure remain limited. Here, we present a two-pronged gene therapy approach that simultaneously augments peak Na
Indexed as
CalciumGenetic TherapyHeart FailureHomeostasisSodiumSodium ChannelsAnimalsChronic DiseaseDependovirusDisease Models, AnimalGenetic VectorsHumansMiceMyocardial ContractionMyocytes, CardiacRabbitsCalciumSodiumSodium-Calcium ExchangerSodium Channels
Identifiers
PMID41861014
PMCPMC13004020
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390